Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Hetlioz Pill

National Institutes of Health

Related topics

Related topics

4 relations
HetliozPills

Narrower (2)

tasimelteon 20 MG Oral Capsule [Hetlioz]tasimelteon Oral Capsule [Hetlioz]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals
Tasimelteon (Hetlioz®) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non… 
  • table 1
Review
2015
Review
2015
Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
Tasimelteon (Hetlioz®), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE